Institute of Health and
Biomedical Innovation

Infectious diseases

Overview

This research area includes the internationally recognised Chlamydia research group, which has multiple research interests covering all aspects of chlamydial disease in humans, wildlife species and livestock.

The Arbovirus group is also widely acclaimed. It is currently running clinical trials of a world first Ross River virus vaccine, and is a major player in studying the molecular epidemiology of dengue viruses in the Asia-Pacific region with the aim of using this information to manipulate the genetic diversity of dengue viruses to control disease.

Members of this research area are also developing state-of-the-art molecular techniques for use in rapid diagnosis of bacterial infections, for profiling of microbial species involved in wound healing and potential bacterial species associated with gastrointestinal conditions such as irritable bowel syndrome. Investigators are also investigating how bacteria such as ureaplasma species can colonise the upper reproductive tract of women undergoing IVF, and how the presence of these bacteria may adversely affect oocyte development, assisted reproductive technology pregnancy outcomes and early neonatal development.

Research programs

  • Chlamydia
  • Arboviruses
  • Bacterial infections

Infrastructure

  • PC2 (physical containment level 2) and PC3 (physical containment level 3) laboratories
  • Animal housing - Medical Engineering Research Facility (MERF)
  • Queensland Tropical Health Alliance

Performance

Developing new researchers

Research students
32
Early career researchers
3

Publication output

2011

Unique count
Total
36
High quality
44%
Author weighting
Total
12
High quality
46%

Research income

2011 total
$1,441,857 (funding split)
2007-2011
$5,361,418 (funding split)

Key grants

  • Australia-Canada-India Chlamydia Research Alliance - National and International Research Alliances Program (NIRAP)

Projects

Projects

This is just a sample of our research activity in this area.

No results were found

Partnerships

International linkages

  • Canada
  • India
  • New Zealand
  • USA
  • Sweden
  • UK
  • Vietnam
  • France
  • Austria
  • Netherlands

Cross-disciplinary engagement

  • Microbiology
  • Virology
  • Genetics
  • Vaccine development

Impact

Evidence of impact

  • Koala vaccine trial
  • International application of Dengue diagnostic test
  • Vaccine development
  • Microbial genomics
  • Benefits to health, agriculture and species conservation

Research enquiries

IHBI research enquiries

Contact us to find out about research and discovery at the Institute of Health and Biomedical Innovation (IHBI).